E-QURE Corp. engages in providing medical devices. The company is headquartered in New York City, New York. The company went IPO on 2001-07-11. The Company’s device is designed to specifically address many of the limitations associated with other invasive and non-invasive wound care devices. The Company’s BST Device stimulates renewed blood flow and oxygen to induce local cell regeneration and therefore promote wound healing. The BST Device is designed to treat chronic wounds primarily Stage III and Stage IV ulcers. The BST Device is a device for adjunctive therapy in wound healing. The BST Device is able to automatically adjust the electric pulse amplitude based on a patient's impedance reading.